HopeStage
Back to overview

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Topics
More filters

Some studies do not list a clear city. Always confirm the location with the study team.

Some visits may still be in person. Participation depends on the study’s location and eligibility requirements.

4317studies shown
Showing 193-204 of 4,317
Behavioral study icon
RecruitingNCT06793397

CYB003 with psychological support for major depression

About this title

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

Read the official source — NCT06793397
What is this study about?

This study evaluates the safety and effectiveness of CYB003 for people with depression.

Multiple locations, including Birmingham
DepressionMedication studyAges 18–85
Countries
United States, Australia, United Kingdom, + 5 others
Sponsor
Cybin IRL Limited
Device study icon
RecruitingNCT06770998

EEG neurofeedback for post-traumatic stress symptoms

About this title

A Study of a Novel EEG Neurofeedback System for PTSD Treatment

Read the official source — NCT06770998
Official study title

A Prospective Randomized Study of a Novel EEG Neurofeedback System for the Treatment of PTSD Using Machine Learning-Based Amygdala Biomarkers

Multiple locations, including Birmingham
PTSDDevice studyAges 18–65
Countries
United States
Sponsor
Foundation for Atlanta Veterans Education and Research, Inc.
Other study type icon
RecruitingNCT06305741

MAC anxiety-support program for Latino older adults with cancer and caregivers

About this title

A Study of an Anxiety Intervention for Latino/Latina/Hispanic Older Adults With Cancer and Their Caregivers

Read the official source — NCT06305741
Official study title

Managing Anxiety From Cancer (MAC): Evaluation of a Tailored Anxiety Intervention for Latino Older Adults With Cancer and Their Caregivers

Multiple locations, including Basking Ridge
AnxietyInterventional studyAges 40+
Countries
United States
Sponsor
Memorial Sloan Kettering Cancer Center
Drug study icon
RecruitingNCT07286175

Brenipatide in adults with Bipolarity (RENEW-Bipolar-1)

What is this study about?

Researchers compare brenipatide with placebo, both added to usual treatment, to find out whether it delays a new mood episode in adults with bipolarity. They monitor changes in symptoms and the safety of the added medicine.

Multiple locations, including Orange
BipolarityMedication studyAges 18–75
Countries
United States, Argentina, Brazil, + 4 others
Sponsor
Eli Lilly and Company
Drug study icon
RecruitingNCT07412756

Brenipatide in adults with Major Depressive Disorder

What is this study about?

This study evaluates the safety and effectiveness of Brenipatide for people with depression.

Multiple locations, including Moorpark
DepressionMedication studyAges 18–75
Countries
United States, Australia, Canada, + 11 others
Sponsor
Eli Lilly and Company
Drug study icon
RecruitingNCT07410507

Brenipatide in adults with Schizophrenia

What is this study about?

This study evaluates the safety and effectiveness of Brenipatide for people with schizophrenia.

Multiple locations, including Little Rock
SchizophreniaMedication studyAges 18–55
Countries
United States, Argentina, Brazil, + 4 others
Sponsor
Eli Lilly and Company
Drug study icon
RecruitingNCT07420283

Brenipatide in people with Addiction

Official study title

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study With a Separate Open-label Cohort to Evaluate the Efficacy and Safety of Brenipatide as Adjunctive Treatment to Transmucosal Buprenorphine With or Without Naloxone in Early Recovery of Participants With Opioid Use Disorder (RENEW-Op-1)

Multiple locations, including Phoenix
AddictionMedication studyAges 18–75
Countries
United States, Canada, United Kingdom
Sponsor
Eli Lilly and Company

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.